In Brief: laxatives warning, FTC settlement, ChromaDex inks 5LINX deal
This article was originally published in The Tan Sheet
Executive Summary
Sodium phosphate laxatives linked to SAERs; FTC scrutinizes personalized supplement claims; NAD refers Xlear LLC to FTC; ChromaDex inks marketing deal with 5LINX; CVS launches vitamin sales, info hub on its website; Star Scientific shareholder suit proceeds.